Protein induces self-destruction in cancer cells

January 21, 2015
Protein induces self-destruction in cancer cells
Overexpression of protein PTP4A3 (red) promotes the maturation of autophagosomes (yellow), triggering the self-destruction of healthy cells and promoting cancer cell growth in ovarian cancer. Credit: A*STAR Institute of Molecular and Cell Biology

The role of a phosphatase protein in promoting the self-destruction of healthy cells and the progression of ovarian cancer has been identified by A*STAR researchers. Known to be overexpressed in cancer cells, the protein, which is called PTP4A3, could be useful as a biomarker for disease prognosis.

In order to grow and spread, actively exploit some of the body's natural cellular processes. One example of such a process is the self-destruction and recycling of long-lived or damaged cells in the body. This process is known as and is necessary for maintaining .

Autophagy is carried out by organelles known as autophagosomes, whose job is to 'dismantle' cells and transport the unwanted cellular material to be recycled into new membranes and proteins. Autophagosomes go through a maturation process during autophagy, which allows them to carry out their role effectively.

Through performing a series of experiments investigating the role of PTP4A3 in cancer progression, Qi Zeng and co-workers at the A*STAR Institute of Molecular and Cell Biology in Singapore, together with other scientists in Singapore and the UK, have uncovered links between the overexpression of PTP4A3 and the acceleration of autophagosome maturation that occurs during autophagy.

"Our experiments on the expression of PTP4A3 in cells led us to discover that the protein exploits the autophagy pathway in order to promote cancer cell growth," says Zeng.

The researchers found that PTP4A3 accumulates in autophagosomes, accelerating their . This in turn encourages the destruction of healthy cells and allows the cancer to take hold (see image). Unexpectedly, Zeng and her team also discovered that PTP4A3 itself then submits to autophagy at a later stage. In this way, PTP4A3 appears to act as a 'fine tuner', restoring balance to the autophagic system after the cancer has progressed.

Following analysis of a large set of data taken from ovarian cancer patients, the team found that high levels of PTP4A3 together with autophagy genes were significantly correlated with poor prognosis in human ovarian cancer patients. "This means that PTP4A3 levels could potentially act as a useful biomarker for prognosis in the future," explains Zeng.

In addition, the researchers found that the inhibition of autophagy reduced PTP4A3-driven in their experiments.

"This study suggests that autophagy could be used as a potential target for arresting PTP4A3-driven tumor progression in patients with high expression of both PTP4A3 and autophagy genes," says Zeng.

Explore further: Discovery of protein that regulates cellular recycling yields new drug targets

More information: Huang, Y.-H., Al-aidaroos, A. Q. O., Yuen, H.-F., Zhang, S.-D., Shen, H.-M. et al. "A role of autophagy in PTP4A3-driven cancer progression." Autophagy 10, 1787–1800 (2014).

Related Stories

Discovery of protein that regulates cellular recycling yields new drug targets

June 2, 2014
Researchers at the University of Michigan have discovered a key regulator of autophagy, the cellular recycling process involved in many human diseases. The finding illuminates potential new drug targets for cancer, neurodegeneration ...

Study highlights new drug, molecular insight into triple negative breast cancers

April 10, 2014
Most breast cancers are treated by blocking their addictions, for example depriving estrogen-fueled tumors of estrogen. But what about breast cancers without these hormonal addictions? In so-called "triple negative" tumors ...

Researchers find new target for kidney cancer therapy

November 10, 2014
Cincinnati Cancer Center (CCC) researchers have discovered that a membrane channel, Transient Receptor Potential Melastatin 3, or TRPM3, promotes growth of kidney cancer tumors, and targeting this channel therapeutically ...

Research reveals mechanism behind cell protein remodeling

September 3, 2014
The remodeling of a kitchen or bathroom changes the appearance of the room and improves its functionality. As investigators at Rutgers Cancer Institute of New Jersey and Rutgers and Princeton Universities have demonstrated, ...

Scientists find how cancers can evade treatment

January 15, 2015
The drugs were designed to keep cancer cells at bay by preventing their growth, survival and spread. Yet, after clinical trials, they left scientists scratching their heads and drug developers watching their investments succumb ...

Zombie cancer cells eat themselves to live

April 5, 2014
A University of Colorado Cancer Center study recently published in the journal Cell Reports and presented today at the American Association for Cancer Research (AACR) Annual Conference 2014 shows that the cellular process ...

Recommended for you

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.